Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 154, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.113570
Keywords
LncRNA; LINC01234; Human cancers; Biological function; Mechanism; Biomarker
Funding
- Province Medical Science and Technology Research Program (Jointly Co -construction) Project of Henan [LHGJ20210324]
- National Natural Science Foundation of China [82103282]
Ask authors/readers for more resources
Abnormal expression of lncRNA LINC01234 is associated with various cancers and may serve as a potential biomarker for cancer diagnosis, treatment, and prognosis.
Abnormal expression of long non-coding RNAs (lncRNAs) plays an essential role in various malignant neoplasia. As a newly identified lncRNA, LINC01234 is abnormally expressed in several types of cancers and promotes the development of cancers. Accumulating evidence indicates that overexpression of LINC01234 is associated with poor clinical outcomes. Moreover, LINC01234 modulates many cellular events as a putative proto-oncogene, including proliferation, migration, invasion, apoptosis, cell cycle progression, and EMT. In terms of molecular mechanism, LINC01234 regulates gene expression by acting as ceRNA, participating in signaling pathways, interacting with proteins and other molecules, and encoding polypeptide. It reveals that LINC01234 may serve as a potential biomarker for cancer diagnosis, treatment, and prognosis. This review summarizes the expression pattern, biological function, and molecular mechanism of LINC01234 in human cancer and discusses its potential clinical utility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available